The history of government price-control policies that seek to impose price ceilings on goods and services…
CFIF on X CFIF on YouTube
Ramirez Cartoon: Drug Price Control Poison

The history of government price-control policies that seek to impose price ceilings on goods and services is both long and replete with failure. That’s because price controls discourage innovation and investment, and lead to shortages in the marketplace, among other unintended consequences.

No targeted industry is immune from the predictable negative impacts of prices controls – not even prescription drugs, which seem to be a primary target in the price-control crosshairs of policymakers at all levels of government.

In his latest cartoon, two-time Pulitzer Prize winner Michael Ramirez sums up the negative consequences of prescription drug price control policies – whether they take the form of direct price caps, “negotiated” Medicare and other prices, or Most Favored Nation…[more]

May 28, 2025 • 01:05 PM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
CFIF Web Video Urges Congress to Pass PERA and the Prevail Act to Strengthen America’s Patent System Print
By CFIF Staff
Monday, November 11 2024

New web video features legal and policy experts explaining how a series of U.S. court decisions and lopsided PTAB proceedings have weakened America’s patent system.

WASHINGTON, DC – The Center for Individual Freedom (CFIF) today released a new web video, backed by a digital ad buy, urging Congress to pass the Patent Eligibility Restoration Act (PERA) and Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act, bipartisan bills that will help restore certainty and fairness for America’s innovators.

The web video features legal and policy experts who have appeared on CFIF’s IP Protection Matters podcast explaining how a series of U.S. court decisions and lopsided proceedings at the Patent Trial and Appeal Board (PTAB) have weakened America’s patent system. CFIF is releasing the web video as the U.S. Senate Judiciary Committee is preparing to mark up PERA and the PREVAIL Act, which would help clarify patent eligibility and provide balance to PTAB proceedings, this week.

Watch the video below:

“China and other foreign competitors are working to surpass the United States as the world’s innovation leader,” said CFIF President Jeffrey Mazzella. “The stakes couldn’t be higher. Yet, the legal uncertainty on patent eligibility and tipping of the PTAB scales against patent holders have weakened America’s patent system. It’s time to reassert America’s leadership to unleash U.S. innovation. It’s time for Congress to act on PERA and the PREVAIL Act.” 

The legal and policy experts appearing in the web video include: The Honorable Paul R. Michel, former Chief Judge on the U.S. Court of Appeals for the Federal Circuit; Alden Abbott, Senior Research Fellow at Mercatus Center and former General Counsel at the Federal Trade Commission; Chris Israel, Executive Director of Alliance of U.S. Startups and Inventors for Jobs; James Edwards, Founder and Executive Director of Conservatives for Property Rights; and Karen Kerrigan, President & CEO of the Small Business & Entrepreneurship Council.

CFIF is a constitutional and free-market advocacy organization with more than 300,000 supporters and activists nationwide. CFIF's IP Protection Matters project is a podcast interview series examining notable issues related to the protection of and threats to intellectual property.

###

Notable Quote   
 
"The 'first 100 days' of a new presidential administration used to refer to a flurry of presidentially signed laws or executive orders. Nowadays, it refers to a blizzard of nationwide injunctions and temporary restraining orders by numerous partisan federal judges who seek to paralyze a presidential administration they don't like.According to the Congressional Research Service, in the first 100 days…[more]
 
 
— Michael Lind, Tablet Magazine
 
Liberty Poll   

Is it even rational to believe that Iran's nuclear weapon ambitions can be conclusively ended without Iranian regime change?